JPMorgan downgraded InnovAge (INNV) to Underweight from Neutral with a $5 price target The company operates within a sensitive market and is subject to higher scrutiny from both state and federal regulators, which has presented an extended headwind to growth prospects over the past three years, the analyst tells investors in a research note. The firm cites lingering headwinds to InnovAge’s long-term growth prospects presented by regulatory scrutiny from both state and federal regulators for the downgrade.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INNV: